Sharing the news on Tuesday (13th July), Belluscura said the medical equipment provider is located in the upper Midwest US and has multiple stores in several states and an online store.
The distributor issued its first purchase order with anticipated delivery of the X-PLO2R™ portable oxygen concentrator expected in less than 90 days.
On the news, Robert Rauker, CEO of Belluscura, said, “Having the X-PLO2R™ portable oxygen concentrator available in stores for potential customers to hold and feel, we believe, will help drive sales of the units. We look forward to commercial launch which we anticipate to start in just a few months.”
Belluscura’s announcement marks the next stage in establishing US-wide distribution coverage as part of its commercialisation strategy.
As described in the company’s admission document, Belluscura’s plan to appoint distributors in the US to give US-wide coverage for the launch of the X-PLO2R.